Related Experiment Video

Updated: Aug 5, 2026

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
09:44

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Published on: April 12, 2011

Respiratory failure due to muscle weakness in inflammatory myopathies: maintenance therapy with home mechanical

A Selva-O'Callaghan1, L Sanchez-Sitjes, X Muñoz-Gall

  • 1Department of Internal Medicine and. Pneumology Service, Vall D'Hebron General Hospital, Barcelona, Spain.

Rheumatology (Oxford, England)
|August 22, 2000
PubMed

Insights

Idiopathic inflammatory myopathies like polymyositis can cause respiratory failure. Home mechanical ventilation improved chronic hypoventilation and quality of life in three patients unresponsive to immunosuppressants.

Area of Science:

  • Neurology
  • Pulmonology
  • Rheumatology

Background:

  • Polymyositis and dermatomyositis are idiopathic inflammatory myopathies.
  • Respiratory complications are common, but severe ventilatory insufficiency is rare.
  • Muscle weakness can lead to respiratory failure in these conditions.

Observation:

  • Three patients with polymyositis presented with respiratory failure due to muscle weakness.
  • These patients did not respond to standard immunosuppressive therapies.
  • Chronic hypoventilation persisted despite medical treatment.

Findings:

  • Home mechanical ventilation, specifically nasal or tracheal intermittent positive pressure, was initiated.
  • This intervention led to significant improvement in chronic hypoventilation.
  • Patients experienced enhanced quality of life with non-invasive ventilation.

Implications:

  • Home mechanical ventilation is a viable and potentially life-saving treatment for respiratory failure in inflammatory myopathies.
  • Non-invasive ventilation can effectively manage chronic hypoventilation when immunosuppressive therapy fails.
  • This approach offers a significant benefit to patients with severe muscle weakness impacting respiratory function.

More Related Videos

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease09:24

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease

Published on: April 17, 2017

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide04:16

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide

Published on: January 30, 2026

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...